Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts
Ardelyx, Inc (NASDAQ:ARDX) is a biotech company. It makes drugs for gut and kidney conditions.
Ardelyx Inc. (ARDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 16,202,700 | $82,633,770 | +771% | 0.76% |
| 2. | Millennium Management Israel Englander | 13,900,773 | $70,893,942 | -23% | 0.03% |
| 3. | AIGH Investment Partners Orin Hirschman | 3,200,000 | $16,320,000 | 1.03% | |
| 4. | AQR Capital Management Cliff Asness | 2,316,220 | $11,812,722 | -6% | 0% |
| 5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 2,241,769 | $11,433,022 | -3% | 0.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.84 | 333,333 | $1,946,331.39 | 3,302,918 | 2026-02-20 | Filing | |
| $3.63 | 200,000 | $725,880.00 | 2,896,871 | 2025-06-16 | Filing | |
| $3.69 | 200,000 | $737,260.00 | 2,696,871 | 2025-06-09 | Filing | |
| $3.29 | 100,000 | $329,120.00 | 2,496,871 | 2025-05-15 | Filing | |
| $4.22 | 381,377 | $1,610,936.45 | 2,396,871 | 2025-05-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.86 | 1,558 | $6,009.05 | 227,520 | 2026-08-21 | Filing | |
| $3.86 | 1,110 | $4,281.16 | 145,854 | 2026-08-21 | Filing | |
| $3.86 | 2,872 | $11,077.02 | 146,964 | 2026-08-21 | Filing | |
| $3.86 | 2,469 | $9,522.69 | 317,095 | 2026-08-21 | Filing | |
| $3.86 | 17,281 | $66,651.09 | 319,564 | 2026-08-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,504,630 | $119,873,615 | 0% | |
| 2. | 13,356,128 | $68,116,253 | 0% | |
| 3. | 10,471,494 | $53,404,619 | 0% | |
| 4. | 9,546,732 | $48,688,000 | 0.07% | |
| 5. | 8,026,774 | $40,936,547 | 0% |
News See All
10 Best Low Priced Stocks to Get Rich in 2026
In this article, we will take a look at the best low priced stocks to get rich in 2026. These days, everyone is focusing on finding ways to get rich.
Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot
In this article, we will discuss Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot.
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2026 Earnings Call Transcript
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2026 Earnings Call Transcript April 30, 2026Ardelyx, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13.
Ardelyx, Inc. (NASDAQ:ARDX) Q4 2025 Earnings Call Transcript
Ardelyx, Inc. (NASDAQ:ARDX) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Welcome to the Ardelyx Fourth Quarter 2025 Earnings Conference.
Ardelyx, Inc. (ARDX) Reports Strong 2025 Revenue Growth, Updates 2026 Outlook
We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. Ardelyx, Inc.
10 Best Long Term Healthcare Stocks to Buy
In this article, we will discuss 10 Best Long Term Healthcare Stocks to Buy.
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Ardelyx, Inc. is next on our list.
20 Best Biotech Stocks Under $20 to Buy Now
In this article, we will be taking a look at the 20 Best Biotech Stocks Under $20 to Buy Now. The U.S.
10 Best Small-Cap Stocks Ready to Explode in 2026
In this article, we will look at the 10 Best Small-Cap Stocks Ready to Explode in 2026.
Hedge Fund Resource Center